European Journal of Medicinal Chemistry, volume 164, pages 92-105

Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.

Kalinin Stanislav
Sharoyko Vladimir
Sharonova Tatyana
Poli Giulio
Publication typeJournal Article
Publication date2019-02-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor6.7
ISSN02235234, 17683254
Organic Chemistry
Drug Discovery
General Medicine
Pharmacology
Abstract
An expanded set of diversely substituted 1,2,4-oxadiazole-containing primary aromatic sulfonamides was synthesized and tested for inhibition of human carbonic anhydrase I, II, IX and XII isoforms. The initial biochemical profiling revealed a significantly more potent inhibition of cancer-related, membrane-bound isoform hCA IX (reaching into submicromolar range), on top of potent inhibition of hCA XII that is another cancer target. The observed structure-activity relationships have been rationalized by molecular modeling. Comparative single-concentration profiling of the carbonic anhydrase inhibitors synthesized for antiproliferative effects against normal (ARPE-19) and cancer (PANC-1) cell lines under chemically induced hypoxia conditions revealed several candidate compounds selectively targeting cancer cells. More in-depth characterization of these leads revealed two structurally related compounds that showed promising selective cytotoxicity against pancreatic cancer (PANC-1) and melanoma (SK-MEL-2) cell lines.

Citations by journals

1
2
3
4
5
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 5, 9.8%
International Journal of Molecular Sciences
5 publications, 9.8%
Russian Journal of General Chemistry
Russian Journal of General Chemistry, 4, 7.84%
Russian Journal of General Chemistry
4 publications, 7.84%
Journal of Molecular Structure
Journal of Molecular Structure, 4, 7.84%
Journal of Molecular Structure
4 publications, 7.84%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 4, 7.84%
European Journal of Medicinal Chemistry
4 publications, 7.84%
Tetrahedron Letters
Tetrahedron Letters, 3, 5.88%
Tetrahedron Letters
3 publications, 5.88%
Bioorganic Chemistry
Bioorganic Chemistry, 3, 5.88%
Bioorganic Chemistry
3 publications, 5.88%
Journal of Enzyme Inhibition and Medicinal Chemistry
Journal of Enzyme Inhibition and Medicinal Chemistry, 3, 5.88%
Journal of Enzyme Inhibition and Medicinal Chemistry
3 publications, 5.88%
Russian Journal of Organic Chemistry
Russian Journal of Organic Chemistry, 2, 3.92%
Russian Journal of Organic Chemistry
2 publications, 3.92%
Molecular Diversity
Molecular Diversity, 2, 3.92%
Molecular Diversity
2 publications, 3.92%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 2, 3.92%
Journal of Medicinal Chemistry
2 publications, 3.92%
Molecules
Molecules, 1, 1.96%
Molecules
1 publication, 1.96%
European Journal of Organic Chemistry
European Journal of Organic Chemistry, 1, 1.96%
European Journal of Organic Chemistry
1 publication, 1.96%
Inorganics
Inorganics, 1, 1.96%
Inorganics
1 publication, 1.96%
Journal of Heterocyclic Chemistry
Journal of Heterocyclic Chemistry, 1, 1.96%
Journal of Heterocyclic Chemistry
1 publication, 1.96%
Pharmaceuticals
Pharmaceuticals, 1, 1.96%
Pharmaceuticals
1 publication, 1.96%
Scientific Reports
Scientific Reports, 1, 1.96%
Scientific Reports
1 publication, 1.96%
Russian Chemical Bulletin
Russian Chemical Bulletin, 1, 1.96%
Russian Chemical Bulletin
1 publication, 1.96%
Journal of the Indian Chemical Society, 1, 1.96%
Journal of the Indian Chemical Society
1 publication, 1.96%
Seminars in Cancer Biology
Seminars in Cancer Biology, 1, 1.96%
Seminars in Cancer Biology
1 publication, 1.96%
Tetrahedron
Tetrahedron, 1, 1.96%
Tetrahedron
1 publication, 1.96%
Archiv der Pharmazie
Archiv der Pharmazie, 1, 1.96%
Archiv der Pharmazie
1 publication, 1.96%
Progress in Heterocyclic Chemistry
Progress in Heterocyclic Chemistry, 1, 1.96%
Progress in Heterocyclic Chemistry
1 publication, 1.96%
Cancers
Cancers, 1, 1.96%
Cancers
1 publication, 1.96%
Current Medicinal Chemistry
Current Medicinal Chemistry, 1, 1.96%
Current Medicinal Chemistry
1 publication, 1.96%
Medicinal Chemistry Research
Medicinal Chemistry Research, 1, 1.96%
Medicinal Chemistry Research
1 publication, 1.96%
1
2
3
4
5

Citations by publishers

2
4
6
8
10
12
14
16
18
Elsevier
Elsevier, 17, 33.33%
Elsevier
17 publications, 33.33%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 9, 17.65%
Multidisciplinary Digital Publishing Institute (MDPI)
9 publications, 17.65%
Pleiades Publishing
Pleiades Publishing, 6, 11.76%
Pleiades Publishing
6 publications, 11.76%
Springer Nature
Springer Nature, 5, 9.8%
Springer Nature
5 publications, 9.8%
Wiley
Wiley, 3, 5.88%
Wiley
3 publications, 5.88%
Taylor & Francis
Taylor & Francis, 3, 5.88%
Taylor & Francis
3 publications, 5.88%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 3.92%
American Chemical Society (ACS)
2 publications, 3.92%
Scientific Publishers, 1, 1.96%
Scientific Publishers
1 publication, 1.96%
Bentham Science
Bentham Science, 1, 1.96%
Bentham Science
1 publication, 1.96%
2
4
6
8
10
12
14
16
18
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Krasavin M. et al. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. // European Journal of Medicinal Chemistry. 2019. Vol. 164. pp. 92-105.
GOST all authors (up to 50) Copy
Krasavin M., Shetnev A. A., Sharonova T., Baykov S. V., Kalinin S., Nocentini A., Sharoyko V., Poli G., Tuccinardi T., Presnukhina S., Tennikova T. B., T Supuran C. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. // European Journal of Medicinal Chemistry. 2019. Vol. 164. pp. 92-105.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ejmech.2018.12.049
UR - https://doi.org/10.1016%2Fj.ejmech.2018.12.049
TI - Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.
T2 - European Journal of Medicinal Chemistry
AU - Krasavin, Mikhail
AU - Shetnev, Anton A
AU - Sharonova, Tatyana
AU - Baykov, Sergey V
AU - Kalinin, Stanislav
AU - Nocentini, Alessio
AU - Sharoyko, Vladimir
AU - Poli, Giulio
AU - Tuccinardi, Tiziano
AU - Presnukhina, Sofia
AU - Tennikova, T. B.
AU - T Supuran, Claudiu
PY - 2019
DA - 2019/02/01 00:00:00
PB - Elsevier
SP - 92-105
VL - 164
SN - 0223-5234
SN - 1768-3254
ER -
BibTex
Cite this
BibTex Copy
@article{2019_Krasavin,
author = {Mikhail Krasavin and Anton A Shetnev and Tatyana Sharonova and Sergey V Baykov and Stanislav Kalinin and Alessio Nocentini and Vladimir Sharoyko and Giulio Poli and Tiziano Tuccinardi and Sofia Presnukhina and T. B. Tennikova and Claudiu T Supuran},
title = {Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.},
journal = {European Journal of Medicinal Chemistry},
year = {2019},
volume = {164},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016%2Fj.ejmech.2018.12.049},
pages = {92--105},
doi = {10.1016/j.ejmech.2018.12.049}
}
Found error?